Feeds › Patents
Patents
New US patents granted to public companies.
About this data
- What it is
- The US Patent and Trademark Office (USPTO) grants new patents every Tuesday. We match the companies named as owners to public companies.
- Who files it
- The USPTO publishes each grant.
- How current
- Grants are published every Tuesday, and we collect them weekly.
- Worth knowing
- A patent count says little about how valuable the patents are. We match owners to companies automatically, so a few may be missed.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Patents granted per week, last 12 weeks
Latest patent grants
Showing: ticker NVS
| Granted | Patent | Owner | Type | Source |
|---|---|---|---|---|
| Nov 10, 2026 | 12790344 10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1′,2′… | NVS Novartis AG | utility | Google Patents ↗ |
| Oct 27, 2026 | 12774275 Compounds and compositions for the treatment of coronaviral related d… | NVS Novartis AG | utility | Google Patents ↗ |
| Oct 20, 2026 | 12767731 Anti-IgE antibody therapy for multiple food allergies | NVS Novartis AG | utility | Google Patents ↗ |
| Oct 20, 2026 | 12767723 Treatment for lupus nephritis using anti-BAFFR antibodies | NVS Novartis AG | utility | Google Patents ↗ |
| Oct 20, 2026 | 12767647 Glue degraders and methods of use thereof | NVS Novartis AG | utility | Google Patents ↗ |
| Oct 13, 2026 | 12760031 Pyridine-3-carboxylate compounds as CAV1.2 activators | NVS Novartis AG | utility | Google Patents ↗ |
| Oct 13, 2026 | 12758539 Method of treating an autoimmune hematological disorder | NVS Novartis AG | utility | Google Patents ↗ |
| Oct 6, 2026 | 12751949 Crystalline forms of a BTK inhibitor | NVS Novartis AG | utility | Google Patents ↗ |
| Sep 29, 2026 | 12747272 Compositions and methods for selective protein degradation | NVS Novartis AG | utility | Google Patents ↗ |
| Sep 22, 2026 | 12741024 Pharmaceutical products and stable liquid compositions of IL-17 antib… | NVS Novartis AG | utility | Google Patents ↗ |
| Sep 15, 2026 | 12735502 Immunoglobulin variants | NVS Novartis AG | utility | Google Patents ↗ |
| Sep 8, 2026 | 12729202 Compounds and compositions as Sppl2a inhibitors | NVS Novartis AG | utility | Google Patents ↗ |
| Sep 1, 2026 | 12723096 Regimens and methods of treating multiple sclerosis using ofatumumab | NVS Novartis AG | utility | Google Patents ↗ |
| Aug 25, 2026 | 12714739 Methods of treating HIV-HAART induced partial lipodystrophy with FGF2… | NVS Novartis AG | utility | Google Patents ↗ |
| Aug 11, 2026 | 12703762 Reversal binding agents for anti-factor XI/XIa antibodies and uses th… | NVS Novartis AG | utility | Google Patents ↗ |
| Aug 11, 2026 | 12702711 Pharmaceutical products and stable liquid compositions of IL-17 antib… | NVS Novartis AG | utility | Google Patents ↗ |
| Aug 4, 2026 | 12697439 Injection device and injection solution transferring system | NVS Novartis AG | utility | Google Patents ↗ |
| Jul 21, 2026 | 12685790 Stable, concentrated radiopharmaceutical composition | NVS Novartis AG | utility | Google Patents ↗ |
| Jul 14, 2026 | 12679834 Bicyclic compounds and their uses | NVS Novartis AG | utility | Google Patents ↗ |
| Jul 14, 2026 | 12679814 Synthesis of prostate specific membrane antigen (PSMA) ligands | NVS Novartis AG | utility | Google Patents ↗ |
| Jul 14, 2026 | 12678415 Use of nicotinic acetylcholine receptor alpha 7 activators | NVS Novartis AG | utility | Google Patents ↗ |
| Jun 30, 2026 | 12668569 Synthesis of prostate specific membrane antigen (PSMA) ligands | NVS Novartis AG | utility | Google Patents ↗ |
| Jun 23, 2026 | 12666232 Communication module for an autoinjector | NVS Novartis AG | utility | Google Patents ↗ |
| Jun 16, 2026 | 12655226 Cell secreted minibodies and uses thereof | NVS Novartis AG | utility | Google Patents ↗ |
| Jun 16, 2026 | 12655115 Synthesis of prostate specific membrane antigen (PSMA) ligands | NVS Novartis AG | utility | Google Patents ↗ |
| Jun 16, 2026 | 12653885 Polyomavirus neutralizing antibodies | NVS Novartis AG | utility | Google Patents ↗ |
| Jun 16, 2026 | 12653850 Combination therapy using a chimeric antigen receptor | NVS Novartis AG | utility | Google Patents ↗ |
| Jun 16, 2026 | 12653807 Modified release formulation for (-)-(3AR,4S,7AR)-4-hydroxy-4-m-tolyl… | NVS Novartis AG | utility | Google Patents ↗ |
| Jun 9, 2026 | 12649781 Methods for treating diabetic retinopathy using brolucizumab | NVS Novartis AG | utility | Google Patents ↗ |
| Jun 9, 2026 | 12648936 Isothiazolidine 1,1-dioxide and 1,4-butan sultone containing rapamyci… | NVS Novartis AG | utility | Google Patents ↗ |
| Jun 2, 2026 | 12642789 Carboxamide derivatives | NVS Novartis AG | utility | Google Patents ↗ |
| May 19, 2026 | 12630633 Antibody molecules to PD-1 and uses thereof | NVS Novartis AG | utility | Google Patents ↗ |
| May 19, 2026 | 12630604 Methods of making chimeric antigen receptor-expressing cells | NVS Novartis AG | utility | Google Patents ↗ |
| May 12, 2026 | 12624118 Trispecific binding molecules against BCMA and uses thereof | NVS Novartis AG | utility | Google Patents ↗ |
| May 5, 2026 | 12617774 Substituted indole compounds and methods of use thereof | NVS Novartis AG | utility | Google Patents ↗ |
| May 5, 2026 | 12616700 Therapeutic regimen | NVS Novartis AG | utility | Google Patents ↗ |
| Apr 21, 2026 | 12606636 Treatment of cancer using humanized anti-CD19 chimeric antigen recept… | NVS Novartis AG | utility | Google Patents ↗ |
| Apr 21, 2026 | 12605506 Automatic drug delivery device | NVS Novartis AG | utility | Google Patents ↗ |
| Apr 21, 2026 | 12605451 Targeted plasma protein degradation | NVS Novartis AG | utility | Google Patents ↗ |
| Apr 14, 2026 | 12600777 Combination therapies comprising antibody molecules to LAG-3 | NVS Novartis AG | utility | Google Patents ↗ |
| Apr 14, 2026 | 12600769 Stable and soluble antibodies inhibiting VEGF | NVS Novartis AG | utility | Google Patents ↗ |
| Apr 14, 2026 | 12600728 Interleukin-17 inhibitors | NVS Novartis AG | utility | Google Patents ↗ |
| Apr 14, 2026 | 12599664 Pharmaceutical products and stable liquid compositions of IL-17 antib… | NVS Novartis AG | utility | Google Patents ↗ |
| Apr 7, 2026 | 12595306 TREM2 stabilizing antibodies | NVS Novartis AG | utility | Google Patents ↗ |
| Apr 7, 2026 | 12595305 TREM2 stabilizing antibodies | NVS Novartis AG | utility | Google Patents ↗ |
| Apr 7, 2026 | 12594333 Methods of treating inflammatory arthritis using IL-17 antagonists | NVS Novartis AG | utility | Google Patents ↗ |
| Apr 7, 2026 | 12594332 Methods of treating psoriasis with secukinumab | NVS Novartis AG | utility | Google Patents ↗ |
| Apr 7, 2026 | 12594331 Methods of treating psoriasis with secukinumab | NVS Novartis AG | utility | Google Patents ↗ |
| Apr 7, 2026 | 12594321 Bispecific chimeric antigen receptor that binds CD19 and CD20, encodi… | NVS Novartis AG | utility | Google Patents ↗ |
| Mar 10, 2026 | 12570754 Regimens and methods of treating multiple sclerosis using ofatumumab | NVS Novartis AG | utility | Google Patents ↗ |
Full history on every feed is part of Premium. Premium loads older rows, up to 10,000, and CSV downloads.
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:22 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Clinical trial updates · FDA approvals and clearances